News Roundup | Prominent Indian Physician Talks Impact Of Ivermectin In Home Medicine Kits in India

Story 1 | Prominent Indian Physician Talks Impact Of Ivermectin In Home Medicine Kits in IndiaTrialSite News chronicled closely the use of ivermectin-based home medicine kits in India’s largest state, Uttar Pradesh, and other states during the second wave of the pandemic starting in March and running through April. TrialSite News shared that by June cases plummeted to what is today’s far more contained situation.Article Link | https://trialsitenews.com/prominent-indian-physician-verifies-huge-impact-of-ivermectin-in-curbing-second-delta-variant-wave-in-india/

Story 2 | FDA Approves First COVID-19 Vaccine: Why Are they Rushing?The U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.Article Link | https://trialsitenews.com/fda-approves-...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee